ClinicalTrials.Veeva

Menu

A Parallel Study Evaluating the Safety of Lactospore® in Healthy Individuals (14PSHS)

KGK Science logo

KGK Science

Status and phase

Completed
Phase 1

Conditions

Healthy

Treatments

Other: Placebo
Dietary Supplement: Lactospore

Study type

Interventional

Funder types

Industry

Identifiers

Details and patient eligibility

About

The purpose of this study is to determine whether Lactospore is safe in healthy adults.

Enrollment

40 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Male or female ≥18 years of age
  • If female, subject is not of child bearing potential or female subject of childbearing potential must agree to use a medically approved method of birth control and have a negative urine pregnancy test result.
  • Healthy as determined by laboratory results and medical history
  • Normal BMI 18.5 - 29.9 kg/m2
  • Has given voluntary, written, informed consent to participate in the study

Exclusion criteria

  • Women who are pregnant, breastfeeding, or planning to become pregnant during the course of the trial
  • Subject has any clinically significant medical conditions
  • Subject requires the use of prescribed medications (other than birth control)
  • Use of illicit drugs or history of drug or alcohol abuse with the past 5 years (currently having more than 2 standard alcoholic drinks per day)
  • Participation in a clinical research trial within 30 days prior to randomization
  • Clinically significant abnormal laboratory results at screening
  • Allergy or sensitivity to test product ingredients
  • Individuals who are cognitively impaired and/or who are unable to give informed consent
  • Any other condition which in the Investigator's opinion may adversely affect the subject's ability to complete the study or its measures or which may pose significant risk to the subject

Trial design

40 participants in 2 patient groups, including a placebo group

Lactospore
Experimental group
Description:
One tablet once daily, 30 minutes before a meal, preferably in the morning for 30 days
Treatment:
Dietary Supplement: Lactospore
Placebo
Placebo Comparator group
Description:
One tablet once daily, 30 minutes before a meal, preferably in the morning, for 30 days.
Treatment:
Other: Placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems